title: Percutaneous ablation of malignant thoracic tumors.
abstract: Lung cancer is the leading cause of death related to cancer. Fifteen to thirty percent of patients with a localized lung cancer are actually inoperable as they present with poor general condition, limited cardiopulmonary function, or a too high surgical risk. Therefore, minimally invasive treatments are needed and percutaneous ablation seems an attractive option. Thermal ablation can be performed by delivering heat (radiofrequency, microwave, laser) or cold (cryotherapy) through a needle inserted into the tumor under CT guidance. The ideal lesion is less than 2 or 3 cm in diameter. Success of percutaneous thermal ablation appears to be close to those of surgery for localized lung cancer. Nevertheless studies are still needed to definitely assess the role of ablation compared to other emerging techniques, as stereotactic radiotherapy as well as potential synergy with other treatments.
authors: Department of Radiology, Cliniques Universitaires St Luc, Catholic University of Louvain, Brussels, Belgium.
authors: B
authors: B
authors: Ghaye
mesh_terms: D017115:Catheter Ablation / Q000379:methods*; D003452:Cryosurgery / Q000379:methods*; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000601:surgery*; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D011859:Radiography; D025321:Surgery, Computer-Assisted / Q000379:methods*; D019616:Thoracic Surgical Procedures / Q000379:methods*